Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
IMPORTANCE: Neuromyelitis optica (NMO) is an inflammatory disease of the optic nerves and spinal cord that leads to blindness and paralysis. Effective immunosuppression is the standard of care for relapse prevention. OBJECTIVE: To compare the relapse and treatment failure rates among patients receiv...
Автори: | Mealy, M, Wingerchuk, D, Palace, J, Greenberg, B, Levy, M |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2014
|
Схожі ресурси
Схожі ресурси
-
Treatment of Neuromyelitis Optica: Review and Recommendations.
за авторством: Kimbrough, D, та інші
Опубліковано: (2012) -
Treatment of neuromyelitis optica: Review and recommendations
за авторством: Kimbrough, D, та інші
Опубліковано: (2012) -
Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
за авторством: Tackley, G, та інші
Опубліковано: (2016) -
TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
за авторством: Elsone, L, та інші
Опубліковано: (2012) -
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
за авторством: Levy M, та інші
Опубліковано: (2021-08-01)